Oralpeptide The peptide industry is experiencing a significant surge, driven by advancements in peptide synthesis and the expanding therapeutic applications of peptides. This dynamic sector, encompassing both peptide therapeutics and peptide synthesis, is projected for substantial growth in the coming years, attracting considerable investment and innovation.
Market Growth and Projections:
The global peptide therapeutics market is a key indicator of the industry's expansion. In 2023, this market was valued at an impressive $43.45 billion and is expected to continue its upward trajectory. Projections indicate that the global peptide therapeutics market size was estimated at USD 117.26 billion in 2024 and is anticipated to reach USD 260.25 billion by 2030, demonstrating a robust compound annual growth rate (CAGR). Other forecasts suggest the global peptide therapeutics market could reach USD 87.21 billion by 2035.Peptide therapeutics The US Peptide Therapeutics Market alone is projected to be $52.6 billion in 2025, with a global projection exceeding $100 billion by 2034.
Similarly, the peptide synthesis market is also witnessing considerable growth. Valued at $0.PolyPeptide - Peptides, Peptide Synthesis and Custom ...78 billion in 2023, it reached $0.81 billion in 2024 and is projected to grow at a healthy 11.7% CAGR, hitting $1作者:M Wang·2025·被引用次数:4—The cosmetics sector also relies onpeptidesfor their ability to stimulate collagen production, enhance skin regeneration, and deliver anti-aging benefits, ....41 billion by 2029.Who is the largest peptide manufacturer | Future Outlook 2025 Further projections indicate the global peptide synthesis market is expected to grow from USD 3Bachem: Peptide & Oligo Manufacturer & CDMO.8 billion in 2025 to USD 4.2 billion in 2026 and USD 6Therapeutic Peptides Control Strategy: Perspective on Current ....0 billion by 2035, at a CAGR of 9.Greening the synthesis of peptide therapeutics39%. The Peptide API Market is also a significant contributor, with its size estimated to reach $75 billion by 2031, growing at a remarkable CAGR of 19Peptide Synthesis Market Size, Share | Growth Report [2034].9% during the forecast period of 2025-2031.
Therapeutic Applications and Advancements:
Peptide therapeutics are peptides or polypeptides that are used to for the treatment of diseases.PolyPeptide - Peptides, Peptide Synthesis and Custom ... Their small size and ability to interact with specific biological targets make them highly effective drug candidates. Peptide drugs accounted for a significant proportion of the pharmaceutical market, with worldwide sales exceeding $70 billion in 2019. In 2022, peptide drugs represented 5% of the global pharmaceutical market, valued at USD 42.2025年11月17日—The global peptide therapeutics market sizeis calculated at USD 54.57 billion in 2026and is expected to reach around USD 81.5 billion by 2034, ...05 billion, with further growth anticipated.The Peptide API Market sizeis estimated to reach Billion by 2031, growing at a CAGR of 19.9% during the forecast period 2025-2031.
The therapeutic potential of peptides spans a wide range of medical conditionsPeptide API Market Size, Share | Industry Trend & Forecast .... They are being developed for the treatment of cancer, metabolic disorders, cardiovascular diseases, and infectious diseases, among others. Breakthrough therapies are continually emerging, expanding the scope of what peptide therapeutics can achieve.
Industry Players and Manufacturing:
The peptide industry is populated by a range of influential companiesPeptides as Therapeutic Agents: Challenges and ... - PMC - NIH. Among the prominent players in the Peptide Therapeutics Market are Bayer AG, AstraZeneca, Amgen IncBachem is a leading, innovation-driven companyspecializing in the development and manufacture of peptides and oligonucleotides.., Merck KGaA, Novartis AG, Pfizer Inc., and Novo Nordisk A/S.Peptide Therapeutics Market Size to Hit USD 87.21 Billion ... Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. PolyPeptide stands out as a market leader in peptide API manufacturing and services, operating as a Contract Development & Manufacturing Organization (CDMO) that supports pharmaceutical companies. CordenPharma offers large scale GMP Peptide manufacturing via SPPS & LPPS, with integrated sterile injectable pre-filled Syringes (PFS) services, highlighting the critical role of industrial scale production.Differences in impurities, particularlypeptide-related impurities, may affect the safety or effectiveness of apeptidedrug product as compared to the RLD.
Emerging Trends and Challenges:
While the peptide industry is experiencing robust growth, there are also emerging trends and challenges to consider. The rise of unapproved chemicals being pitched as performance enhancers or anti-aging solutions is a concern, with regulatory bodies like the FDA's policy shift tightening controls across the peptide manufacturing landscape. This underscores the importance of adhering to current industry control strategies and ensuring the safety and efficacy of peptide products.
Furthermore, there is a growing emphasis on greening the synthesis of peptide therapeutics, with researchers focusing on methods pertaining to solvent substitution and reduction for large-scale industrial production.Answer : The global peptide therapeutics market sizeis accounted at USD 52.59 billion in 2025and is expected to reach around USD 87.21 billion by 2035.
Broader Applications of Peptides:
Beyond therapeutics, peptides have gained significant traction in other sectorsThe trend of unproven peptides is spreading through .... In the cosmetic field, peptides are highly valued for their ability to stimulate collagen production, enhance skin regeneration, and deliver anti-aging benefits, contributing to solutions for anti-aging, whitening, moisturizing, and skin repairThe trend of unproven peptides is spreading through .... Their small size and ability to penetrate the skin make them increasingly popular in both cosmetic and medical fields.
The peptide industry is a dynamic and rapidly evolving sector, poised for continued innovation and market expansion, impacting both healthcare and consumer products.
Join the newsletter to receive news, updates, new products and freebies in your inbox.